tiprankstipranks
Trending News
More News >
ABVC BioPharma, Inc. (ABVC)
NASDAQ:ABVC
US Market

ABVC BioPharma, Inc. (ABVC) Income Statement

Compare
101 Followers

ABVC BioPharma, Inc. Income Statement

Last quarter (Q3 2024), ABVC BioPharma, Inc.'s total revenue was $389.28K, an increase of 2350.74% from the same quarter last year. In Q3, ABVC BioPharma, Inc.'s net income was $-186.56K. See ABVC BioPharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 152.43K$ 969.78K$ 355.80K$ 483.05K$ 701.72K
Gross Profit
$ -149.61K$ 683.37K$ 350.71K$ 464.33K$ 681.58K
Operating Expenses
$ 8.07M$ 15.80M$ 11.70M$ 8.97M$ 4.14M
Depreciation and Amortization
$ 28.53K$ 23.80K$ 11.99K$ 37.14K$ 55.09K
EBITDA
$ -8.13M$ -15.20M$ -10.97M$ -10.37M$ -3.47M
Operating Income
$ -8.22M$ -15.11M$ -11.35M$ -8.51M$ -3.46M
Other Income/Expenses
$ -2.44M$ -400.18K$ 495.14K$ -2.31M$ -551.50K
Pretax Income
$ -10.65M$ -15.51M$ -11.21M$ -10.81M$ -4.01M
Net Income
$ -10.52M$ -16.31M$ -12.04M$ -10.59M$ -3.93M
Per Share Metrics
Basic EPS
$ -2.43$ -5.15$ -4.80$ -5.37$ -2.25
Diluted EPS
$ -2.43$ -5.15$ -4.80$ -5.37$ -2.25
Weighted Average Shares Outstanding
4.34M 3.17M 2.51M 1.97M 1.75M
Weighted Average Shares Outstanding (Diluted)
4.34M 3.17M 2.51M 1.97M 1.75M
Currency in USD

ABVC BioPharma, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis